Kovil Rajiv, Chawla Manoj, Rajput Rajesh, Singh A K, Sinha Binayak, Ghosal Samit, Ballani Piya, Gupta Sunil, Tanna Snehal, Bandukwala S M, Shah Tejas, Negalur Vijay, Bhoraskar Anil, Aravind S R, Zargar Abdul H, Kesavadev Jothydev, Das Ashok Kumar
Consultant Diabetologist, Kovil Diabetes Center, Mumbai.
Consultant Diabetologist, BSES Municipal General Hospital, Mumbai.
J Assoc Physicians India. 2017 Feb;65(2):17-30.
Insulin is the oldest of the currently available treatment options in Type 2 diabetes mellitus (T2DM) and is considered as the most effective glucose lowering agent. Despite this, decision on starting insulin therapy is often delayed in India as well as worldwide due to various barriers at both patient and physician levels. Appropriate insulin dosing and titration is also critical to the successful achievement of tight glycaemic control.
To provide simple and easily implementable guidelines to primary care physicians on appropriate insulin dosing and titration of various insulin regimens for both initiation and intensification.
Each insulin regimen (once daily [OD] basal, OD, twice daily and thrice daily premixed, basal-plus and basal-bolus) was presented and evaluated for dosing and titration based on established guidelines, data from approved pack inserts, and published scientific literature. These evaluations were then factored into the national context based on the expert committee representatives patient-physician experience in their clinical practice and common therapeutic practices followed in India.
Recommendations for dosing and titration of basal, basal-plus, premixed and basal-bolus insulins were developed. The key recommendations are that insulin doses can be adjusted once or twice weekly; adjustment can be based on lowest/mean of three recent self-monitoring of plasma glucose pre-meal/fasting plasma glucose (FPG) values. The titration should be based on FPG or pre-meal value of 80-130 mg/dL and the dose should be reduced by 10-20% for patients reporting hypoglycaemia(<70mg/dL).
The consensus based recommendations mentioned in this paper will be a useful reference tool for health care practitioners, to initiate, optimise and intensify insulin therapy and to successfully achieve optimal glucose control.
胰岛素是目前2型糖尿病(T2DM)可用治疗方案中最古老的一种,被认为是最有效的降糖药物。尽管如此,在印度以及全球范围内,由于患者和医生层面的各种障碍,启动胰岛素治疗的决定往往会延迟。适当的胰岛素剂量调整和滴定对于成功实现严格的血糖控制也至关重要。
为基层医疗医生提供关于各种胰岛素治疗方案起始和强化时适当胰岛素剂量调整和滴定的简单且易于实施的指南。
介绍了每种胰岛素治疗方案(每日一次[OD]基础胰岛素、OD、每日两次和每日三次预混胰岛素、基础加餐时胰岛素和基础-餐时胰岛素),并根据既定指南、批准的药品说明书数据和已发表的科学文献对剂量调整和滴定进行评估。然后,根据专家委员会代表在临床实践中的患者-医生经验以及印度普遍遵循的治疗实践,将这些评估纳入本国实际情况。
制定了基础胰岛素、基础加餐时胰岛素、预混胰岛素和基础-餐时胰岛素剂量调整和滴定的建议。关键建议是胰岛素剂量可每周调整一到两次;调整可基于最近三次自我监测的餐前/空腹血糖(FPG)值中的最低值/平均值。滴定应基于FPG或餐前值80 - 130mg/dL,对于报告低血糖(<70mg/dL)的患者,剂量应降低10 - 20%。
本文中基于共识的建议将成为医疗保健从业者启动、优化和强化胰岛素治疗并成功实现最佳血糖控制的有用参考工具。